comparemela.com

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Germany ,Munich ,Bayern ,Scintomics Gmb ,Davide Gauden ,Eugene Teoh ,Technical University Of Munich ,Drug Administration ,Blue Earth Diagnostics ,New Drug Application ,Prostate Specific Membrane Antigen Targeted ,Chief Executive Officer ,Blue Earth ,Blue Earth Diagnostic Phase ,Technical University ,Chief Medical Officer ,Radiohybrid Prostate Specific Membrane Antigen ,Prostate Specific Membrane Antigen ,Scintomics Gmbh ,Emission Tomography ,Prostate Specific Antigen ,

comparemela.com © 2020. All Rights Reserved.